Pride-PM2

Description

Key Ingredients:~

Metformin 500 mg + Glimepiride 2 mg + Pioglitazone 15 mg

Product Info:~

Pride-PM2 is a triple-combination oral antidiabetic medication containing Metformin 500 mg, Glimepiride 2 mg, and Pioglitazone 15 mg. This powerful blend targets multiple pathways to manage type 2 diabetes effectively. Metformin decreases hepatic glucose production, Glimepiride enhances insulin secretion, and Pioglitazone improves insulin sensitivity in peripheral tissues. Together, they provide comprehensive glycemic control, especially in patients with inadequate response to dual therapy. Pride-PM2 is used alongside a proper diet, regular physical activity, and lifestyle adjustments for optimal diabetes management.

Key Benefits:~

• Pride-PM2 offers a comprehensive approach by targeting insulin resistance, secretion, and glucose production.
• It improves glycemic control in patients unresponsive to two-drug combinations.
• It reduces the risk of long-term diabetes complications with sustained use.
• It enhances insulin sensitivity in muscle and adipose tissues.
• It supports better overall metabolic and cardiovascular health when combined with lifestyle changes.

We are a  pharmaceutical company catering to businesses only and offering innovative medicines to enhance healthcare ensuring high quality and effective solutions.